Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 96.52x is 68% below its estimated 1-year average of 298.23x, near the low end of its estimated 1-year range (96.52x–365.09x).
As of 2026-10-06T19:56:17.049Z.
Calculation as of: 2026-10-06T19:56:17.049Z.
Quote observation: 2026-10-06T19:55:21.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4980e4284b6230c79d3dcd5f09fe919c7c05eb80d65ab6e095ba480293e97312
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
96.52x
EV/SALES RATIO AVG TTM
N/A
EV/SALES RATIO AVG 3Y
N/A
EV/SALES RATIO AVG 5Y
N/A
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.39x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
+2098.63%
vs the sector median at left
Canton Strategic Holdings Inc
Market Cap
$181.62M
EV/Sales Ratio
96.52x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$182.79M
EV/Sales Ratio
N/A
TTM Avg
307.72x
3Y Avg
307.72x
5Y Avg
307.72x
Market Cap
$179.26M
EV/Sales Ratio
N/A
TTM Avg
35.88x
3Y Avg
65.08x
5Y Avg
86.67x
Market Cap
$187.95M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$174.46M
EV/Sales Ratio
314.38x
TTM Avg
11.44x
3Y Avg
100.12x
5Y Avg
89.86x
Market Cap
$174.29M
EV/Sales Ratio
2.59x
TTM Avg
4.53x
3Y Avg
5.91x
5Y Avg
29.99x
Market Cap
$190.42M
EV/Sales Ratio
N/A
TTM Avg
4.34x
3Y Avg
5.78x
5Y Avg
5.78x
Market Cap
$172.42M
EV/Sales Ratio
0.42x
TTM Avg
0.84x
3Y Avg
0.94x
5Y Avg
1.17x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Canton Strategic Holdings Inc (CNTN) | $181.62M | 96.52x | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $182.79M | N/A | 307.72x | 307.72x | 307.72x |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | N/A | N/A | N/A | N/A |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | N/A | 35.88x | 65.08x | 86.67x |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $187.95M | N/A | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $174.46M | 314.38x | 11.44x | 100.12x | 89.86x |
| ProQR Therapeutics N.V. (PRQR)vs › | $174.29M | 2.59x | 4.53x | 5.91x | 29.99x |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $190.42M | N/A | 4.34x | 5.78x | 5.78x |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | 0.42x | 0.84x | 0.94x | 1.17x |
| Precision BioSciences, Inc. (DTIL)vs › | $170.58M | 2.50x | 23.43x | 22.39x | 15.48x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 312.90x |
| 2026-10-02 | 301.30x |
| 2026-10-01 | 292.60x |
| 2026-09-30 | 320.15x |
| 2026-09-29 | 320.15x |
| 2026-09-28 | 365.09x |
| 2026-09-25 | 347.69x |
| 2026-09-24 | 310.00x |
| 2026-09-23 | 299.85x |
| 2026-09-22 | 330.30x |
| 2026-09-21 | 328.85x |
| 2026-09-18 | 308.55x |
| 2026-09-17 | 279.55x |
| 2026-09-16 | 270.86x |
| 2026-09-15 | 272.31x |
| 2026-09-14 | 279.55x |
| 2026-09-11 | 281.00x |
| 2026-09-10 | 286.80x |
| 2026-09-09 | 295.50x |
| 2026-09-08 | 298.40x |
| 2026-09-04 | 305.65x |
| 2026-09-03 | 301.30x |
| 2026-09-02 | 276.66x |
| 2026-09-01 | 305.65x |
| 2026-08-31 | 305.65x |
| 2026-08-28 | 296.95x |
| 2026-08-27 | 315.80x |
| 2026-08-26 | 298.40x |
| 2026-08-25 | 310.00x |
| 2026-08-24 | 285.35x |
| 2026-08-21 | 292.60x |
| 2026-08-20 | 295.50x |
| 2026-08-19 | 278.11x |
| 2026-08-18 | 266.51x |
| 2026-08-17 | 269.41x |
